New site of modification of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolates

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 12, 2002, Pages 3765-3769

  Fontana, Carla ^a,b   Favaro, Marco ^a   Minelli, Silvia ^a,b   Criscuolo, Anna Angela ^a,b   Pietroiusti, Antonio ^a   Galante, Alberto ^a   Favalli, Cartesio ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Clinical Microbiology Laboratories   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; MACROLIDE; RIBOSOME RNA; RNA 23S;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; ERADICATION THERAPY; GENE AMPLIFICATION; GENE MUTATION; GENETIC CONSERVATION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RNA STRUCTURE; SEQUENCE ANALYSIS; STOMACH BIOPSY; DRUG EFFECT; GENETICS; ISOLATION AND PURIFICATION; POINT MUTATION;

BASE SEQUENCE; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; HELICOBACTER PYLORI; HUMANS; POINT MUTATION; POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 23S;

EID: 0036894092     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.12.3765-3769.2002     Document Type: Article

References (31)

1. Alarcon, T., D. Domingo, N. Prieto, and M. Lopez-Brea. 2000. PCR using 3′-mismatched primer to detect A2142 C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates. J. Clin. Microbiol. 38:923-925.
2. Burucoa, A., V. Lhomme, and J. L. Fauchere. 1999. Performance criteria of DNA fingerprinting methods for typing of Helicobacterpylori isolates: Experimental results and meta-analysis. J. Clin. Microbiol. 37:4071-4080.
3. Debets-Ossenkopp, Y. J., A. J. Herscheid, R. G. Pot., E. J. Kuipers, J. G. Kusters, and C. M. Vandenbroucke-Grauls. 1999. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in the Netherlands. J. Antimicrob. Chemother. 43:511-515.
4. Debets-Ossenkopp, Y. J., M. Sparrius, J. G. Kusters, J. J. Kolkmann, and C. M. J. E. Vandenbroucke-Grauls. 1996. Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori. FEMS Microbiol. Lett. 142:37-42.
5. Doi, R. H. 1991. Regulation of Gene Expression. p. 15-39. In U. N. Streips and R. E. Yasbin (ed.), Modern microbial genetics. Wiley-Liss, Inc., New York, N.Y.
6. Egebjerg, J., N. Larsen, and R. A. Garret. 1990. Structural map of 23S rRNA, p. 168-179. In W. E. Hill, A. Dahlberg, R. A. Garrett, P. B. Moore, D. Schleissinger, and J. R. Warner (ed.), The Ribosome: Structure, Function and Evolution. American Society for Microbiology, Washington, D.C.
7. European Helicobacter pylori Study Group. 1997. Current European concepts in the management of Helicobacterpylori infection. Gut 41:8-13.
8. Fontana, C., A. Pietroiusti, A. Mastino, E. S. Pistoia, D. Marino, A. Magrini, A. Galante, and C. Favalli. 2000. Comparison of an enzyme immunoassay versus a rapid latex test for serodiagnosis of Helicobacter pylori infection. Eur. J. Clin. Microbiol. Infect. Dis. 19:239-240.
9. Fujimura, S. 2000. Clarithromycin-susceptible Helicobacter pylori with mutation in 23S rRNA gene by PCR-RFLP method. J. Gastroenterol 35:315-316.
10. Garcia-Arata, M. I., F. Baquero, L. De Rafael, C. M. De Argila, J. P. Gisbert, F. Bermejo, D. Boixeda, and R. Cantbn. 1999. Mutations in 23S rRNA in Helicobacterpylori conferring resistance to erythromycin do not always confer resistance to clarithromycin. Antimicrob. Agents Chemother. 43:374-376.
11. Germani, Y., C. Dauga, P. Duval, M. Huerre, M. Levy, G. Pialoux, P. Sansonetti, and P. A. D. Grimont. 1997. Strategy for the detection of Helicobacterpylori species by amplification of 16S rRNA genes and identification of H. felis in human gastric biopsy. Res. Microbiol. 148:315-326.
12. Glupczynski, Y., M. Labbè, W. Hansen, F. Crokaert, and E. Yourassowsky. 1991. Evaluation of the E-test for quantitative antimicrobial susceptibility testing of Helicobacter pylori. J. Clin. Microbiol. 29:2072-2075.
13. Goddard, A. F., and R. P. H. Logan. 1996. Antimicrobial resistance and Helicobacter pylori. J. Antimicrob. Chemother. 37:639-643.
14. Graham, D. Y., W. A. de Boer, and J. T. Tytgat. 1996. Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance. Am. J. Gastroenterol. 91:1072-1076.
15. Kuster, J. G., and and E. J. Kuipeers. 2001. Antibiotic resistance of Helicobacter pylori. Symp. Ser. Soc. Appl. Microbiol. 30:134S-144S.
16. Logan, R. P. H., P. A. Gummett, H. D. Schaufelberger, R. R. F. H. Greaves, G. M. Mendelson, and M. M. Walker. 1994. Eradication of Helicobacter pylori with clarithromycin and omoprazole. Gut 35:323-326.
17. Mirza, S. H., A. Hannan, and F. Rizvi. 1993. Helicobacter pylori: Isolation from gastric biopsy specimens. Ann. Trop. Med. Parasitol. 87:483-486.
18. Monteiro, L., J. Cabrita, and F. Mégraud. 1997. Evaluation of performances of three DNA enzyme immunoassays for detection of Helicobacter pylori PCR products from biopsy specimens. J. Clin. Microbiol. 35:2931-2936.
19. National Committee for Clinical Laboratory Standards. 1997. Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically, 4th Ed.; approved standard M7-A3. National Committee for Clinical Laboratory Standards, Wayne, Pa.
20. National Committee for Clinical Laboratory Standards. 1999. Performance Standard Antimicrobial Susceptibility Testing, 5th Informational Supplement. M100S9. National Committee for Clinical Laboratory Standards, Wayne, Pa.
21. NIH Consensus Conference. 1994. Helicobacterpylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. JAMA 272:65-69.
22. Occhialini, A., M. Urdaci, F. Doucet-Populaire, C. M. Bebear, H. Lamouliatte, and F. Mégraud. 1997. Macrolide resistance in Helicobacterpylori: Rapid detection of point mutations and assays of macrolide binding to ribosome. Antimicrob. Agents Chemother. 41:2724-2728.
23. Osato, M. S. R. Reddy, S. G. Reddy, R. L. Penland, and D. Y. Graham. 2001. Comparison of the E-test and the NCCLS-approved agar dilution method to detect metronidazole and clarithromycin resistant Helicobacter pylori. Intern. J. Antimicrob. Agents 17:39-44.
24. Taylor, D. E., G. Zhongming, D. Purych, T. Lo, and K. Hiratsuka. 1997. Cloning and sequence analysis of two copies of the 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob. Agents Chemother. 41:2621-2628.
25. Torracchio, S., L. Cellini, E. Di Campli, G. Cappello, M. G. Malatesta, A. Ferri, A. F. Ciccaglione, L. Grossi, and L. Marzio. 2000. Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacterpylori eradication. Aliment. Pharmacol. Ther. 14:1639-1643.
26. Vaira, D., J. Holton, M. Miglioli, M. Menegatti, P. Mule, and L. Barbara. 1994. Peptic ulcer disease and Helicobacter pylori infection. Curr. Opin. Gastroenterol. 10:98-104.
27. Van Der Ende, A., L. J. Van Doorn, S. Rooijakkers, M. Feller, G. N. Tytgat, and J. Dankert. 2001. Clarithromycin-susceptible and -resistant Helicobacter pylori isolates with identical randomly amplified polymorphic DNA-PCR genotypes cultured from single gastric biopsy specimens prior to antibiotic therapy. J. Clin. Microbiol. 39:2647-2651.
28. Versalovic, D. Shortridge, K. Kimbler, M. V. Griffy, J. Beyer, R. K. Flamm, S. K. Tanaka, D. Y. Graham, and M. F. Go. 1996. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 40:477-480.
29. Versalovic, J., M. S. Osato, K. Spakovsky, M. P. Dore, R. Reddy, G. G. Stone, D. Shortridge, R. K. Flamm, S. K. Tanaka, and D. Y. Graham. 1997. Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. Antimicrob. Agents Chemother. 40:283-286.
30. Vester, B., and S. Douhwaite. 2001. Macrolide resistance conferred by base substitutions in the 23S rRNA. Antimicrob. Agents Chemother. 45:1-12.
31. Wang, G., and D. Taylor. 1998. Site-specific mutations in the 23S rRNA gene of Helicobacter pylori confer two types of resistance to Macrolide-lincosamide-Streptogramin B Antibiotics. Antimicrob. Agents Chemother. 42: 1952-1958.